These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3166923)
1. Ankylosing spondylitis lung disease and Mycobacterium scrofulaceum. Levy H; Hurwitz MD; Strimling M; Zwi S Br J Dis Chest; 1988 Jan; 82(1):84-7. PubMed ID: 3166923 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis. Gacad G; Massaro D Am Rev Respir Dis; 1974 Feb; 109(2):274-8. PubMed ID: 4811782 [No Abstract] [Full Text] [Related]
8. Pulmonary disease associated with mycobacteria other than tubercle bacilli in miners. Nel EE; Linton WS; Van Der Merwe W; Berson SD; Kleeberg HH S Afr Med J; 1977 May; 51(22):779-83. PubMed ID: 877805 [TBL] [Abstract][Full Text] [Related]
9. The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. Hjelt K; Højlyng N; Howitz P; Illum N; Munk E; Valerius NH; Fursted K; Hansen KN; Heltberg I; Koch C Scand J Infect Dis; 1994; 26(5):569-76. PubMed ID: 7855554 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterium celatum pulmonary infection mimicking pulmonary tuberculosis in a patient with ankylosing spondylitis. Tan CK; Lai CC; Chou CH; Hsueh PR Int J Infect Dis; 2009 Nov; 13(6):e459-62. PubMed ID: 19269205 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous presentation of upper lobe fibrobullous disease and spinal pseudarthrosis in a patient with ankylosing spondylitis. Hakala M; Kontkanen E; Koivisto O Ann Rheum Dis; 1990 Sep; 49(9):728-9. PubMed ID: 2241293 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Anderson DH; Grech P; Townshend RH; Jephcott AE Clin Radiol; 1975 Oct; 26(4):461-9. PubMed ID: 1201641 [TBL] [Abstract][Full Text] [Related]
14. [Bi-apical pulmonary fibrosis during ankilosing spondylitis: A report on 5 cases (author's transl)]. Chatel A; Blanchon F; Bigot JM; Cremniter D; Hélénon C; Brocard H J Radiol; 1980; 61(6-7):451-5. PubMed ID: 7401027 [TBL] [Abstract][Full Text] [Related]
15. Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy. Yoo JW; Jo KW; Kang BH; Kim MY; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS Eur Respir J; 2014 Nov; 44(5):1289-95. PubMed ID: 25102962 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001-2011: A case series and literature review. Suzuki S; Morino E; Ishii M; Namkoong H; Yagi K; Asakura T; Asami T; Fujiwara H; Uwamino Y; Nishimura T; Tasaka S; Betsuyaku T; Takasaki J; Iwata S; Hasegawa N J Infect Chemother; 2016 Sep; 22(9):611-6. PubMed ID: 27406572 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary diffuse amyloidosis and ankylosing spondylitis. A rare association. Blavia R; Toda MR; Vidal F; Benet A; Razquin S; Richart C Chest; 1992 Nov; 102(5):1608-10. PubMed ID: 1424904 [TBL] [Abstract][Full Text] [Related]
19. Non tuberculous mycobacteria (NTM) in patients with underlying diseases: results obtained by using polymerase chain reaction-restriction enzyme analysis between 1997-2002. Ergin A; Hascelik G New Microbiol; 2004 Jan; 27(1):49-53. PubMed ID: 14964405 [TBL] [Abstract][Full Text] [Related]